Home / Tag Archives: PARP inhibitor

Tag Archives: PARP inhibitor

June, 2018

May, 2018

January, 2018

December, 2017

October, 2017

June, 2017

April, 2017

  • 20 April

    AbbVie’s PARP Inhibitor Fails Two Late-Stage Cancer Trials

    NORTH CHICAGO, Ill., April 19, 2017 /PRNewswire/ — AbbVie, a global biopharmaceutical company, today announced that two Phase 3 studies evaluating veliparib, an investigational, oral poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor did not meet their primary endpoints. The studies evaluated veliparib in combination with the chemotherapy regimen carboplatin and …